EP2563385
Aðferðir til notkunar á leysanlegum CD24 við meðferð á liðagigt
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.4.2011EP published:
2.8.2017EP application number:
11778000.7
EP translation filed:
9.10.2017Grant published:
15.11.2017EPO information:
European Patent Register
Max expiry date:
27.4.2031Expiry date:
27.4.2024
Title:
METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS
Timeline
Today
28.4.2011EP application
2.8.2017EP Publication
9.10.2017Translation submitted
15.11.2017Registration published
27.4.2024Expires
Owner
Name:
Oncoimmune Inc.Address:
12111 Parklawn Drive, Suite 107, 20852-1707, Rockville, MD, US
Inventor
Name:
ZHENG, XinchengAddress:
Ann Arbor, MI, US
Name:
WU, WeiAddress:
Ann Arbor, MI, US
Name:
LIU, YangAddress:
Ann Arbor, MI, US
Name:
ZHENG, PanAddress:
Ann Arbor, MI, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
329078 PDate:
28.4.2010Country:
US
Classification
Categories:
A61K 38/17, A61P 19/02, C07K 14/705
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 3.4.2018
Expires: 27.4.2019
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 2.4.2019
Expires: 27.4.2020
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 20.4.2020
Expires: 27.4.2021
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 31.3.2021
Expires: 27.4.2022
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 21.3.2022
Expires: 27.4.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 21.3.2023
Expires: 27.4.2024
Payer: Árnason Faktor ehf.